Mário Miguel Rosa

5.8k total citations · 1 hit paper
66 papers, 3.5k citations indexed

About

Mário Miguel Rosa is a scholar working on Neurology, Cellular and Molecular Neuroscience and Cognitive Neuroscience. According to data from OpenAlex, Mário Miguel Rosa has authored 66 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Neurology, 10 papers in Cellular and Molecular Neuroscience and 8 papers in Cognitive Neuroscience. Recurrent topics in Mário Miguel Rosa's work include Parkinson's Disease Mechanisms and Treatments (39 papers), Neurological disorders and treatments (25 papers) and Botulinum Toxin and Related Neurological Disorders (8 papers). Mário Miguel Rosa is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (39 papers), Neurological disorders and treatments (25 papers) and Botulinum Toxin and Related Neurological Disorders (8 papers). Mário Miguel Rosa collaborates with scholars based in Portugal, Italy and Netherlands. Mário Miguel Rosa's co-authors include Joaquim J. Ferreira, Miguel Coelho, Cristina Sampaio, Leonor Correia Guedes, Ferruccio Fazio, Daniela Perani, Marco Tettamanti, Stefano F. Cappa, Tiago Mestre and João Costa and has published in prestigious journals such as New England Journal of Medicine, PLoS ONE and Brain.

In The Last Decade

Mário Miguel Rosa

62 papers receiving 3.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Rivastigmine for Dementia Associated with Parkinson's Disease

2004 793 citations Murat Emre, Dag Aarsland et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mário Miguel Rosa Portugal	27	1.7k	715	568	526	509	66	3.5k
Bruce H. Price United States	31	1.0k 0.6×	1.1k 1.5×	509 0.9×	882 1.7×	351 0.7×	81	3.7k
Christian Brenneis Austria	37	1.5k 0.9×	680 1.0×	979 1.7×	277 0.5×	595 1.2×	87	3.8k
Scott J. Sherman United States	28	1.4k 0.8×	1.2k 1.6×	1.1k 1.9×	256 0.5×	558 1.1×	71	3.4k
John V. Hindle United Kingdom	30	1.5k 0.9×	911 1.3×	296 0.5×	960 1.8×	150 0.3×	65	3.3k
Elena Sinforiani Italy	34	960 0.6×	864 1.2×	501 0.9×	1.0k 1.9×	471 0.9×	140	3.8k
Lisa M. Shulman United States	36	3.1k 1.8×	533 0.7×	618 1.1×	1.2k 2.3×	250 0.5×	105	4.6k
David F. Tang‐Wai Canada	36	1.9k 1.1×	1.6k 2.2×	795 1.4×	1.6k 3.0×	436 0.9×	125	5.0k
Hakan Gürvıt Türkiye	31	917 0.5×	665 0.9×	367 0.6×	641 1.2×	627 1.2×	171	3.7k
Jorge Matías‐Guiu Spain	35	1.3k 0.8×	594 0.8×	289 0.5×	1.0k 1.9×	507 1.0×	239	3.9k
Donna Masterman United States	20	886 0.5×	594 0.8×	366 0.6×	1.4k 2.6×	314 0.6×	38	3.5k

Countries citing papers authored by Mário Miguel Rosa

Since Specialization

Citations

This map shows the geographic impact of Mário Miguel Rosa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mário Miguel Rosa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mário Miguel Rosa more than expected).

Fields of papers citing papers by Mário Miguel Rosa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mário Miguel Rosa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mário Miguel Rosa. The network helps show where Mário Miguel Rosa may publish in the future.

Co-authorship network of co-authors of Mário Miguel Rosa

This figure shows the co-authorship network connecting the top 25 collaborators of Mário Miguel Rosa. A scholar is included among the top collaborators of Mário Miguel Rosa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mário Miguel Rosa. Mário Miguel Rosa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Barbosa, Raquel, Paulo Bastos, Patrícia Pita Lobo, et al.. (2025). Differential Effects of Levodopa and Stimulation on Post‐Surgery Freezing of Gait in Subthalamic Nucleus Deep Brain Stimulation Parkinson's Disease Patients: A Clinical and Kinematic Analysis. Movement Disorders Clinical Practice. 12(11). 1859–1872. 1 indexed citations

Bouça‐Machado, Raquel, et al.. (2022). Adverse Events of Physiotherapy Interventions in Parkinsonian Patients. Movement Disorders Clinical Practice. 9(6). 744–750. 5 indexed citations

Dionísio, Pedro A., Leonor Correia Guedes, Nilza Gonçalves, et al.. (2020). Circulating Inflammatory miRNAs Associated with Parkinson’s Disease Pathophysiology. Biomolecules. 10(6). 945–945. 39 indexed citations

Costa, João, et al.. (2020). Impact of dementia on informal care: a systematic review of family caregivers’ perceptions. BMJ Supportive & Palliative Care. 14(e1). e38–e49. 198 indexed citations

Fabbri, Margherita, Miguel Coelho, Daisy Abreu, et al.. (2019). Dysphagia predicts poor outcome in late-stage Parkinson's disease. Parkinsonism & Related Disorders. 64. 73–81. 29 indexed citations

Martins, Joana, Rui Almeida, Daniel Caldeira, et al.. (2019). Efficacy and safety of sirolimus in the treatment of vascular anomalies: A systematic review. Journal of Vascular Surgery. 71(1). 318–327. 115 indexed citations

Miranda, Hugo Vicente, Leonor Correia Guedes, Marcos António Gomes, et al.. (2017). Posttranslational modifications of blood-derived alpha-synuclein as biochemical markers for Parkinson’s disease. Scientific Reports. 7(1). 85 indexed citations

Fabbri, Margherita, Isabel Guimarães, Rita M. Cardoso, et al.. (2017). Speech and Voice Response to a Levodopa Challenge in Late-Stage Parkinson’s Disease. Frontiers in Neurology. 8. 432–432. 48 indexed citations

Coelho, Miguel, Daisy Abreu, Leonor Correia Guedes, et al.. (2017). Disability in Activities of Daily Living and Severity of Dyskinesias Determine the Handicap of Parkinson’s Disease Patients in Advanced Stage Selected to DBS. Journal of Parkinson s Disease. 7(2). 255–261. 1 indexed citations

10.

Fabbri, Margherita, Miguel Coelho, Leonor Correia Guedes, et al.. (2017). Acute response of non-motor symptoms to subthalamic deep brain stimulation in Parkinson's disease. Parkinsonism & Related Disorders. 41. 113–117. 19 indexed citations

11.

Cerreta, Francesca, Joël Ankri, David Bowen, et al.. (2016). BASELINE FRAILTY EVALUATION IN DRUG DEVELOPMENT. The Journal of Frailty & Aging. 5(3). 1–2. 8 indexed citations

12.

Fabbri, Margherita, Mário Miguel Rosa, & Joaquim J. Ferreira. (2016). Clinical Pharmacology Review of Opicapone for the Treatment of Parkinson’s Disease. Neurodegenerative Disease Management. 6(5). 349–362. 17 indexed citations

13.

Reimão, Sofia, Patrícia Pita Lobo, Dulce Neutel, et al.. (2015). Quantitative Analysis Versus Visual Assessment of Neuromelanin MR Imaging for the Diagnosis of Parkinson’s disease. Journal of Parkinson s Disease. 5(3). 561–567. 13 indexed citations

14.

Coelho, Miguel, M. J. Martí, Cristina Sampaio, et al.. (2014). Dementia and severity of parkinsonism determines the handicap of patients in late‐stage Parkinson's disease: the Barcelona−Lisbon cohort. European Journal of Neurology. 22(2). 305–312. 33 indexed citations

15.

Rosa, Mário Miguel, et al.. (2010). Prescribing patterns of antiparkinsonian agents in Europe. Movement Disorders. 25(8). 1053–1060. 21 indexed citations

16.

Guedes, Leonor Correia, Joaquim J. Ferreira, Mário Miguel Rosa, et al.. (2009). Worldwide frequency of G2019S LRRK2 mutation in Parkinson's disease: A systematic review. Parkinsonism & Related Disorders. 16(4). 237–242. 127 indexed citations

17.

Coelho, Miguel, Joaquim J. Ferreira, Mário Miguel Rosa, & Cristina Sampaio. (2008). Treatment options for non-motor symptoms in late-stage Parkinson's disease. Expert Opinion on Pharmacotherapy. 9(4). 523–535. 20 indexed citations

18.

Ferreira, Joaquim J., Luís Almeida, Luı́s Cunha, et al.. (2008). Effects of Nebicapone on Levodopa Pharmacokinetics, Catechol-O-methyltransferase Activity, and Motor Fluctuations in Patients with Parkinson Disease. Clinical Neuropharmacology. 31(1). 2–18. 26 indexed citations

19.

Emre, Murat, Dag Aarsland, Alberto Albanese, et al.. (2004). Rivastigmine for Dementia Associated with Parkinson's Disease. New England Journal of Medicine. 351(24). 2509–2518. 793 indexed citations breakdown →

20.

Perani, Daniela, Stefano F. Cappa, Tatiana T. Schnur, et al.. (1999). The neural correlates of verb and noun processing. Brain. 122(12). 2337–2344. 384 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact